Visa has integrated the Monad blockchain into its stablecoin settlement program, allowing issuers and acquirers to settle payments via Monad alongside nine other supported blockchains like Ethereum and Solana. This expansion reflects Visa's strategy of being blockchain and stablecoin agnostic, supporting multiple networks to facilitate real money movement through stablecoins. The program's annualized settlement volume surged from $7 billion to $25 billion within a year, highlighting rapid growth in stablecoin usage for payments. Monad's inclusion signals growing credibility for the chain in the payments ecosystem, though challenges like regulatory clarity and operational complexity remain.
Visa's addition of Monad to its stablecoin settlement network comes with this market snapshot from Pluang as of Nov 10, 2026 20:44 WIB: Among 50 major cryptocurrencies priced on Pluang, 14 rose and 35 fell today. Notable movers include BAT at Rp2.354 with a 1-day change of +2.73% and a Pluang order activity of 99% Buy, SOL at Rp1.522.157 down -2.67% with 73% Sell activity, and XNO at Rp5.788 up +2.64% with 100% Buy activity. The most notable figure is BAT's 99% Buy order activity.
project44 has partnered with Snowflake to enhance supply chain decision-making through Mo, an AI-powered supply chain analyst. Mo uses project44's extensive logistics data and Snowflake Cortex AI to provide accurate, consistent answers to complex sup...
H&R Block has launched the Emerald Advance Loan, a fixed-rate short-term loan up to $1,750 with a 35.90% APR, designed to help families cover year-end expenses without monthly payments. Borrowers repay the loan in full by March 31, 2027, with no impa...
Duke Robotics has entered a strategic collaboration with Greek security firm CRONOS to commercialize its Insulator Cleaning Drone (IC Drone) technology in Greece. This partnership leverages CRONOS's strong presence in Greece's critical infrastructure...
Alm. Brand A/S repurchased 1,369,397 shares between November 3 and 9, 2026, at an average price of DKK 17.46 per share. This is part of their announced buy-back program totaling up to DKK 593 million, aiming to reduce the number of outstanding shares...
Novartis has secured first place in the 2026 Access to Medicine Index, maintaining its lead since 2024 by excelling across all assessed technical areas, including governance, R&D, and product delivery. The company scored 3.86 out of 5 overall, with a...
